Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting, 3rd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 528
Special Issue Editors
Interests: cancer; chemoresistance; nucleolar stress; extra-ribosomal function of ribosomal proteins; cell cycle
Special Issues, Collections and Topics in MDPI journals
Interests: tumorigenesis; cancer therapy; TP53, TGFβ, TNFα signaling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
According to the World Health Organization, cancer is the most common cause of premature death in developed countries. Conventional cancer treatment involves the therapeutic application of chemotherapeutic agents associated with surgical therapy. However, the clinical outcome of this therapeutic approach can be unsatisfactory, especially in patients with advanced disease. Furthermore, common chemotherapeutic drugs show high levels of toxicity for normal cells, which is often associated with the development of chemoresistance. For these reasons, oncological research has focused on finding innovative therapies that increase the specificity of the treatment and reduce their drawbacks. New therapeutic approaches for cancer treatment, currently under evaluation in many clinical trials worldwide, include but are not limited to molecules targeting the nucleolus, natural antioxidants and phytochemicals in combination with common chemotherapeutic drugs, expression of genes triggering apoptosis, tumor suppressors, targeted silencing mediated by siRNAs, and the nanodelivery of chemotherapeutics.
The combination of new and conventional approaches allows oncologists to select the best and most personalized therapy for cancer treatment.
This Special Issue, led by Dr. Giulia Russo and Dr. Annapina Russo with the assistance of our Topical Advisory Panel Members and the GE’s assistant editor Dr. Annalisa Pecoraro (Department of Pharmacy, University of Naples Federico II, 80131 Napoli, Italy), will document studies on the molecular mechanism underlying tumorigenesis and on innovative strategies for cancer treatment.
More published papers could be found in the closed Special Issues: Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting and Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting 2.0.
Dr. Annapina Russo
Dr. Giulia Russo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- nucleolus
- nucleolar stress
- tumorigenesis
- cancer therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
